Inge Marie Svane

Inge Marie Svane

Clinical Professor

Member of:

  • Clinical Oncology


  1. 2022
  2. Published

    Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma

    Mork, S. K., Kadivar, M., Bol, K. F., Draghi, A., Westergaard, M. C. W., Skadborg, S. K., Overgaard, N., Sorensen, A. B., Rasmussen, I. S., Andreasen, L. V., Yde, C. W., Trolle, T., Garde, C., Friis-Nielsen, J., Norgaard, N., Christensen, D., Kringelum, J. V., dqp123, dqp123, Hadrup, S. R. & Svane, Inge Marie, 31 Dec 2022, In: OncoImmunology. 11, 1, 15 p., 2023255.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Immune checkpoint inhibitor treatment and ophthalmologist consultations in patients with malignant melanoma or lung cancer—A nationwide cohort study

    D’Souza, M., Bagger, M., Alberti, M., Malmborg, M., Schou, Morten, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar, Svane, Inge Marie & Kiilgaard, Jens Folke, 1 Jan 2022, In: Cancers. 14, 1, 13 p., 49.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

    Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

    Lorentzen, C. L., Martinenaite, E., Kjeldsen, J. W., Holmstroem, R. B., Mørk, S. K., Pedersen, A. W., Ehrnrooth, E., Andersen, Mads Hald & Svane, Inge Marie, 2022, In: Frontiers in Immunology. 13, 1023023.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells

    Weis-Banke, S. E., Lisle, T. L., Perez Penco, Maria, Schina, A., Hübbe, M. L., Siersbæk, M., Holmström, M. O., Jørgensen, M. A., Svane, Inge Marie, Met, Özcan, Ødum, Niels, Madsen, Daniel Hargbøl, dqp123, dqp123, Grøntved, L. & Andersen, Mads Hald, 2022, In: Journal for ImmunoTherapy of Cancer. 10, 10, e005326.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?

    Lauss, M., dqp123, dqp123, Svane, Inge Marie & Jönsson, G., 2022, In: Clinical Cancer Research. 28, 9, p. 1751–1758 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis

    Holmstroem, R. B., Nielsen, Ole Haagen, Jacobsen, Søren, Riis, Lene Buhl, Theile, S., Bjerrum, Jakob Tveiten , Vilmann, Peter, Johansen, Julia Sidenius, Boisen, M. K., Eefsen, R. H. L., Svane, Inge Marie, Nielsen, Dorte Lisbet & Chen, I. M., 2022, In: Journal for ImmunoTherapy of Cancer. 10, 9

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting

    Pedersen, S., Larsen, K. O., Christensen, Alex Hørby, Svane, Inge Marie, Zerahn, B. & Ellebaek, E., 2022, In: Acta Oncologica. 61, 1, p. 45-51

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Clinical advances and ongoing trials on mRNA vaccines for cancer treatment

    Lorentzen, C. L., Haanen, J. B., Met, Özcan & Svane, Inge Marie, 2022, In: The Lancet Oncology. 23, 10, p. e450-e458

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma

    Ellebaek, E., Schina, A., Andersen, R., Hendel, Helle Westergren, Svane, Inge Marie & dqp123, dqp123, 2022, In: International Journal of Cancer. 150, 11, p. 1870-1878 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 4054758